---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-022762"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2025-08-08T23:59:59+00:00"
generated_at: "2026-05-17T16:19:31.883862+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Xtant Medical sets Nov 7, 2025 for annual meeting; proposal deadline Aug 18, 2025

## Summary
- Annual meeting scheduled for November 7, 2025; proxy statement expected around September 12, 2025.
- Stockholder proposals for proxy inclusion under Rule 14a-8 must be received by August 18, 2025.
- Director nominations and other proposals (non-Rule 14a-8) also due by August 18, 2025.
- Universal proxy rule (Rule 14a-19) compliance deadline for nominees is September 8, 2025.

## SEC filing metadata
- accession: 0001641172-25-022762
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2025-08-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000164117225022762/0001641172-25-022762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000164117225022762/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-022762
- JSON: https://secwatch.observer/filing/0001641172-25-022762.json
- Plain text: https://secwatch.observer/filing/0001641172-25-022762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.